Mohd Hassan Baig
Mohd Hassan Baig
Verified email at yuhs.ac - Homepage
Title
Cited by
Cited by
Year
Computer aided drug design: success and limitations
M Hassan Baig, K Ahmad, S Roy, J Mohammad Ashraf, M Adil, ...
Current pharmaceutical design 22 (5), 572-581, 2016
1592016
Biophysical study on the interaction between eperisone hydrochloride and human serum albumin using spectroscopic, calorimetric, and molecular docking analyses
G Rabbani, MH Baig, EJ Lee, WK Cho, JY Ma, I Choi
Molecular pharmaceutics 14 (5), 1656-1665, 2017
1092017
Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance
S Shaikh, N Nazam, SMD Rizvi, K Ahmad, MH Baig, EJ Lee, I Choi
International journal of molecular sciences 20 (10), 2468, 2019
1062019
Binding of erucic acid with human serum albumin using a spectroscopic and molecular docking study
G Rabbani, MH Baig, AT Jan, EJ Lee, MV Khan, M Zaman, AEA Farouk, ...
International journal of biological macromolecules 105, 1572-1580, 2017
932017
Binding of tolperisone hydrochloride with human serum albumin: effects on the conformation, thermodynamics, and activity of HSA
G Rabbani, EJ Lee, K Ahmad, MH Baig, I Choi
Molecular pharmaceutics 15 (4), 1445-1456, 2018
892018
Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products
S Ahmad, U Shahab, MH Baig, MS Khan, MS Khan, AK Srivastava, ...
PloS one 8 (9), e72128, 2013
872013
Antioxidant and α-amylase inhibitory property of Phyllanthus virgatus L.: an in vitro and molecular interaction study
A Hashim, MS Khan, M Khan, M Baig, S Ahmad
BioMed Research International 2013, 2013
662013
Implication of caspase-3 as a common therapeutic target for multineurodegenerative disorders and its inhibition using nonpeptidyl natural compounds
S Khan, K Ahmad, E Alshammari, M Adnan, MH Baig, M Lohani, ...
BioMed research international 2015, 2015
602015
Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight
MI Khan, ZA Khan, MH Baig, I Ahmad, AEA Farouk, YG Song, JJ Dong
PLoS One 15 (9), e0238344, 2020
422020
Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy
MH Baig, M Adil, R Khan, S Dhadi, K Ahmad, G Rabbani, T Bashir, ...
Seminars in cancer biology 56, 1-11, 2019
392019
Fibromodulin: a master regulator of myostatin controlling progression of satellite cells through a myogenic program
EJ Lee, AT Jan, MH Baig, JM Ashraf, SS Nahm, YW Kim, SY Park, I Choi
The FASEB Journal 30 (8), 2708-2719, 2016
382016
Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
MH Baig, K Ahmad, M Saeed, AM Alharbi, GE Barreto, GM Ashraf, I Choi
Biomedicine & Pharmacotherapy 103, 574-581, 2018
362018
Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: an in silico-updated overview
K Ahmad, M Hassan Baig, G Mushtaq, M Amjad Kamal, N H Greig, I Choi
Current Alzheimer research 14 (11), 1190-1197, 2017
312017
Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study
MH Baig, DR Sudhakar, P Kalaiarasan, N Subbarao, G Wadhawa, ...
PLoS One 9 (12), e112456, 2014
302014
Use of peptides for the management of Alzheimer’s disease: diagnosis and inhibition
MH Baig, K Ahmad, G Rabbani, I Choi
Frontiers in aging neuroscience 10, 21, 2018
282018
Broad-spectrum inhibition of AHL-regulated virulence factors and biofilms by sub-inhibitory concentrations of ceftazidime
FM Husain, I Ahmad, MH Baig, MS Khan, MS Khan, I Hassan, ...
RSC advances 6 (33), 27952-27962, 2016
272016
Identification of high-affinity inhibitors of cyclin-dependent kinase 2 towards anticancer therapy
T Mohammad, S Batra, R Dahiya, MH Baig, IA Rather, JJ Dong, I Hassan
Molecules 24 (24), 4589, 2019
262019
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
MH Baig, AT Jan, G Rabbani, K Ahmad, JM Ashraf, T Kim, HS Min, ...
Scientific reports 7 (1), 1-10, 2017
262017
Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to …
S Roy, A Kumar, MH Baig, M Masařík, I Provazník
Methods 83, 105-110, 2015
262015
Low temperature synthesis of superparamagnetic iron oxide (Fe3O4) nanoparticles and their ROS mediated inhibition of biofilm formed by food-associated bacteria
NA Al-Shabib, FM Husain, F Ahmed, RA Khan, MS Khan, FA Ansari, ...
Frontiers in microbiology 9, 2567, 2018
252018
The system can't perform the operation now. Try again later.
Articles 1–20